Company intelligence / Profile preview

Ruiya International

Boten, Luang Namtha, Laos

Ownership: Private
Development stage: Other

Overview

Ruiya International Medical Center was a healthcare provider specializing in assisted reproductive services and in vitro fertilization (IVF). Based in the Boten Special Economic Zone (SEZ) in Laos, the center was established to offer high-end fertility treatments, including IVF-ET, ICSI, PGS/PGD, and gamete cryopreservation, primarily targeting patients from China. In February 2020, Hong Kong-listed Jinxin Fertility Group acquired the licenses and operations of Ruiya International Medical Center to establish the Jinrui Medical Center. However, due to regulatory and policy uncertainties regarding IVF services in Laos, operations were terminated in 2025.

Therapeutic areas: Women's Health
Industry: Non-Academic Healthcare

Beyond the preview

Go deeper on Ruiya International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ruiya International.

Explore the full profile